Alaunos Therapeutics (TCRT) Other Gross PP&E Adjustments (2016 - 2024)
Historic Other Gross PP&E Adjustments for Alaunos Therapeutics (TCRT) over the last 14 years, with Q4 2024 value amounting to -$64000.0.
- Alaunos Therapeutics' Other Gross PP&E Adjustments rose 9088.32% to -$64000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$64000.0, marking a year-over-year increase of 9088.32%. This contributed to the annual value of -$64000.0 for FY2024, which is 9088.32% up from last year.
- Per Alaunos Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$64000.0 for Q4 2024, which was up 9088.32% from -$702000.0 recorded in Q4 2023.
- Alaunos Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $15.6 million during Q4 2022, with a 5-year trough of -$5.4 million in Q2 2021.
- In the last 5 years, Alaunos Therapeutics' Other Gross PP&E Adjustments had a median value of -$2.0 million in 2023 and averaged -$5235.3.
- Over the last 5 years, Alaunos Therapeutics' Other Gross PP&E Adjustments had its largest YoY gain of 10013.74% in 2021, and its largest YoY loss of 18523.63% in 2021.
- Over the past 5 years, Alaunos Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $6.6 million in 2020, then surged by 100.14% to $13.1 million in 2021, then rose by 18.98% to $15.6 million in 2022, then tumbled by 104.5% to -$702000.0 in 2023, then soared by 90.88% to -$64000.0 in 2024.
- Its Other Gross PP&E Adjustments stands at -$64000.0 for Q4 2024, versus -$702000.0 for Q4 2023 and -$1.0 million for Q3 2023.